Cellromax Science Co., Ltd. (KOSDAQ:471820)
3,945.00
-335.00 (-7.83%)
At close: Jul 20, 2026
-34.25% (1Y)
| Market Cap | 44.88B -33.2% |
| Revenue (ttm) | 20.98B -6.2% |
| Net Income | 3.42B +45.4% |
| EPS | 302.14 +37.6% |
| Shares Out | 11.04M |
| PE Ratio | 13.45 |
| Forward PE | n/a |
| Dividend | 185.00 (4.69%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 5,132 |
| Open | 4,255.00 |
| Previous Close | 4,280.00 |
| Day's Range | 3,945.00 - 4,255.00 |
| 52-Week Range | 3,945.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |